| IoAPS (n = 44) | ItAPS (n = 39) | tAPS+oAPS (n = 9) | P value All groups | P value IoAPS vs. ItAPS |
---|---|---|---|---|---|
Antibody categories | Â | Â | Â | Â | Â |
 Triple positive, n (%) | 11 (25.00) | 18 (46.15) | 6 (66.67) | 0.022 | 0.065 |
 Double positive, n (%) | 7 (15.90) | 9 (23.08) | 1 (11.11) | 0.678 | 0.578 |
  ACL+LA | 0 (0) | 1 (2.56) | 0 (0) | 0.521 | 0.470 |
  LA+anti-β2GPI | 2 (4.55) | 2 (5.13) | 1 (11.11) | 0.632 | 1.000 |
  ACL+anti-β2GPI | 5 (11.36) | 6 (15.38) | 0 (0) | 0.651 | 0.748 |
 Single positive, n (%) | 26 (59.10) | 12 (30.77) | 2 (22.22) | 0.017 | 0.015 |
  ACL | 1 (2.27) | 1 (2.56) | 0 (0) | 1.000 | 1.000 |
  Anti-β2GPI | 23 (52.27) | 7 (17.94) | 1 (11.11) | 0.001 | 0.001 |
  LA | 2 (4.55) | 4 (10.26) | 1 (11.11) | 0.420 | 0.413 |
ESR (mm/h), median (quartile) | 10 (6, 27) | 10 (5,21) | 11 (4.5,27.5) | 0.814 | 0.254 |
CRP (mg/L), median (quartile) | 1.03 (0.56, 3.85) | 1.32 (0.50,3.92) | 9.55 (0.46,10.95) | 0.808 | 0.383 |
Hcy (μmol/L), median (quartile) | 9.90 (8.10, 12.10) | 11.20 (9.70,14.60) | 10.85 (9.08,12.68) | 0.152 | 0.028 |
C3 (g/L), median (quartile) | 0.98 (0.81, 1.17) | 0.92 (0.73,1.12) | 0.75 (0.66,1.11) | 0.235 | 0.129 |
C4 (g/L), median (quartile) | 0.16 (0.13, 0.23) | 0.17 (0.13,0.21) | 0.14 (0.12,0.18) | 0.565 | 0.371 |